HIGHLIGHTS
SUMMARY
To figure out Essential medicines for cardiovascular diseases what to do next, like how to get access to essential medicines for CVD (EM-CVD), it is important to study the availability of the EM-CVD and the challenges they pose for health care systems. In a 2019 study, Kaiser et_al investigated the availability of essential diabetes and CVD medicines, discovering that two anti-diabetics and nine anti-hypertensives had high availability (80%), while the remaining anti-diabetics and anti-hypertensives had availability levels that were mostly under 50% for the rest of the surveyed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.